Victory Capital Management Inc Biocryst Pharmaceuticals Inc Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 24,849 shares of BCRX stock, worth $188,106. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,849

Previous 25,586 2.88%

Holding current value

$188,106

Previous $158,000 18.99%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$6.41 - $8.69 $4,724 - $6,404	-737 Reduced 2.88%	24,849 $188,000
Q2 2024 Aug 05, 2024	SELL	$4.13 - $6.79 $2,304 - $3,788	-558 Reduced 2.13%	25,586 $158,000
Q1 2024 May 03, 2024	SELL	$4.89 - $7.65 $3,413 - $5,339	-698 Reduced 2.6%	26,144 $132,000
Q4 2023 Feb 05, 2024	BUY	$4.98 - $6.77 $32,041 - $43,558	6,434 Added 31.53%	26,842 $160,000
Q3 2023 Nov 06, 2023	BUY	$6.71 - $7.92 $1,335 - $1,576	199 Added 0.98%	20,408 $144,000
Q2 2023 Jul 27, 2023	SELL	$6.96 - $8.81 $3,264 - $4,131	-469 Reduced 2.27%	20,209 $142,000
Q1 2023 May 02, 2023	SELL	$7.94 - $11.84 $20 Million - $29.8 Million	-2,512,906 Reduced 99.18%	20,678 $172,000
Q4 2022 Feb 10, 2023	BUY	$10.5 - $14.2 $1,953 - $2,641	186 Added 0.01%	2,533,584 $29.1 Million
Q4 2022 Feb 09, 2023	SELL	$10.5 - $14.2 $10.4 Million - $14 Million	-986,833 Reduced 28.03%	2,533,398 $29.1 Million
Q3 2022 Nov 02, 2022	SELL	$10.79 - $14.81 $11.3 Million - $15.5 Million	-1,044,699 Reduced 22.89%	3,520,231 $44.4 Million
Q2 2022 Aug 01, 2022	BUY	$7.89 - $17.88 $7.98 Million - $18.1 Million	1,011,409 Added 28.46%	4,564,930 $48.3 Million
Q1 2022 May 04, 2022	BUY	$11.56 - $19.76 $36 Million - $61.5 Million	3,112,255 Added 705.3%	3,553,521 $57.5 Million
Q4 2021 Feb 07, 2022	SELL	$11.18 - $15.46 $256,111 - $354,157	-22,908 Reduced 4.94%	441,266 $6.11 Million
Q3 2021 Nov 02, 2021	SELL	$14.21 - $17.65 $2.69 Million - $3.35 Million	-189,655 Reduced 29.01%	464,174 $6.67 Million
Q2 2021 Aug 03, 2021	SELL	$9.5 - $17.24 $300,722 - $545,732	-31,655 Reduced 4.62%	653,829 $10.3 Million
Q1 2021 May 04, 2021	SELL	$7.37 - $13.61 $1.78 Million - $3.28 Million	-241,195 Reduced 26.03%	685,484 $6.97 Million
Q4 2020 Feb 01, 2021	SELL	$3.37 - $8.61 $912,852 - $2.33 Million	-270,876 Reduced 22.62%	926,679 $6.9 Million
Q3 2020 Nov 09, 2020	BUY	$3.43 - $5.53 $3.11 Million - $5.02 Million	907,591 Added 313.0%	1,197,555 $4.11 Million
Q2 2020 Aug 07, 2020	BUY	$1.9 - $5.61 $503,775 - $1.49 Million	265,145 Added 1068.31%	289,964 $1.38 Million
Q1 2020 May 04, 2020	SELL	$1.6 - $4.11 $1,772 - $4,553	-1,108 Reduced 4.27%	24,819 $50,000
Q4 2019 Feb 04, 2020	BUY	$1.59 - $3.45 $13,747 - $29,828	8,646 Added 50.03%	25,927 $74,000
Q3 2019 Nov 12, 2019	BUY	$2.5 - $3.73 $43,202 - $64,458	17,281 New	17,281 $50,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Biocryst Pharmaceuticals Inc Transaction History